Gradientech Overview

  • Founded
  • 2009
Founded
  • Status
  • Private
  • Employees
  • 17
Employees
  • Latest Deal Type
  • Later Stage VC
  • Latest Deal Amount
  • $9.2M
Latest Deal Amount
  • Investors
  • 10

Gradientech General Information

Description

Developer of microfluidic tools intended to provide live imaging of cell behavior in response to defined concentration gradients. The company develops an IVD system for ultra-rapid antibiotic susceptibility testing (AST) based on their microfluidic gradient generating platform products that helps in the formation of stable gradients of soluble substance in any type of 2D and 3D cell culture, enabling clients to analyze live-cell responses at high resolution and with full control of the chemotactic environment.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Healthcare Technology Systems
Other Industries
Discovery Tools (Healthcare)
Biotechnology
Decision/Risk Analysis
Primary Office
  • Dag Hammarskjölds väg 34A
  • 752 37 Uppsala
  • Sweden
+46 018-418 00 00

Gradientech Timeline

2017201820192020
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Gradientech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Later Stage VC 01-Sep-2020 $9.2M 000.00 Completed Generating Revenue
9. Accelerator/Incubator 27-Mar-2020 00000 000.00 Completed Generating Revenue
8. Later Stage VC 03-Apr-2019 00.000 000.00 Completed Generating Revenue
7. Later Stage VC 30-Aug-2018 00.00 00.000 Completed Generating Revenue
6. Grant 26-Mar-2018 00.00 00.000 Completed Generating Revenue
5. Later Stage VC 09-Dec-2016 00.000 00.000 Completed Generating Revenue
4. Grant 20-Nov-2014 00000 00.00 Completed Generating Revenue
3. Early Stage VC 08-Aug-2013 00.00 00.00 Completed Generating Revenue
2. Seed Round Completed Startup
1. Accelerator/Incubator Completed Startup
To view Gradientech’s complete valuation and funding history, request access »

Gradientech Executive Team (3)

Name Title Board Seat Contact Info
Sara Thorslund Ph.D Co-Founder & Chief Executive Officer
Ann-Sofie Andersson Manager, Sales & Marketing
To view Gradientech’s complete executive team members history, request access »

Gradientech Board Members (12)

Name Representing Role Since
Allan Asp Almi Invest Board Member 000 0000
Camilla Huse Bondesson Self Co-Chairman 000 0000
Gisela Sitbon Ph.D Gradientech Co-Chairman 000 0000
Henrik Didner Ph.D Self Board Member 000 0000
January Närlinge Self Board Member 000 0000
You’re viewing 5 of 12 board members. Get the full list »

Gradientech Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Gradientech Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Axilium Capital Venture Capital Minority 000 0000 000000 0
European Regional Economic Development Fund Corporation 000 0000 000000 0
Tillväxtverket Government 000 0000 000000 0
Uppsala Bio Accelerator/Incubator 000 0000 000000 0
Horizon 2020 Government 000 0000 000000 0
You’re viewing 5 of 10 investors. Get the full list »